Jianhui Jiang

Jianhui Jiang

Auto-generated profile, based on publicly available information

Jianhui Jiang

Department of Radiology, Guangdong Women and Children Hospital, Guangzhou 511442, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Pancreatology
Verified
Journal Article
Closed access
SLShu Liu
Shu Liu
ZWZhiqing Wang
Zhiqing Wang
JJJianhui Jiang
Jianhui Jiang
XLXianqiong Luo
Xianqiong Luo
QHQingshan Hong
Qingshan Hong
WZWeihong Zeng
Weihong Zeng

Verified
Journal Article
Open access
PDF file
SLShu Liu
Shu Liu
YZYe Zhang
Ye Zhang
ZDZhi Deng
Zhi Deng
HHHui He
Hui He
XZXianhua Zheng
Xianhua Zheng
XLXianqiong Luo
Xianqiong Luo
Biotinidase (BTD) deficiency (OMIM 253260) is an autosomal recessively inherited metabolic disorder resulting from deficient activity of the BTD enzyme, which can cleave and release biotin from a variety of biotin-dependent carboxylases, and is therefore recognized as a tool to recycle biotin. Being a condition caused by variations on BTD gene with a consequence of free biotin shortage, BTD deficiency may impair the activity of biotin-dependent carboxylases, and thus bring about a buildup of potentially toxic compounds in the body, primarily 3-hydroxyisovaleryl-carnitine in plasma as well as 3-hydroxyisovaleric acid in urine. The phenotype of BTD deficiency may vary dramatically, from asymptomatic adults to severe neurological anomalies, even death in infancy. In the present study, we reported on a 5-month-old boy, whose parents sought for medical consultation in our clinic for their son due to his loss of consciousness, repeated tetany, and motor retardation. Detailed clinical features included severe psychomotor retardation, hypotonia, as well as failure to thrive. The brain MRI at 12 months showed cerebellar hypoplasia and multiple foci of leukodystrophy. The result of antiepileptic therapy was not satisfying. During hospitalization, BTD deficiency was suggested by elevated concentration of 3-hydroxyisovaleryl-carnitine in the blood spots and 3-hydroxyisovaleric acid in the urine. The child was then diagnosed with profound BTD deficiency based on the above findings and low BTD enzyme activity. Subsequent mutational analysis revealed a novel homozygous variant, c.637_637delC (p.H213Tfs*51) in exon 4 of BTD gene in the proband, which was recognized as a further support to the diagnosis. Therefore, biotin treatment was started immediately, eventually with satisfactory outcomes achieved in terms of prevention of epileptic seizure, performance in deep tendon reflexes, and improvement of muscular hypotonia, but unfortunately, the therapy failed to show any evident effects on poor feeding and intellectual disability. This painful lesson suggests that newborn screening for inherited metabolic diseases is essential for early identification and treatment, which should have been performed in this case to avoid this tragedy.

1 April 2019 in Steroids
Verified
Journal Article
Closed access
SLShu Liu
Shu Liu
ZWZhiqing Wang
Zhiqing Wang
JJJianhui Jiang
Jianhui Jiang
HOHaimei OuYang
Haimei OuYang
SWSisi Wei
Sisi Wei
XXXunjie Xie
Xunjie Xie